SENS compared with RNA: revenue, margins and what each company keeps, and the suppliers and customers both name

SENSSenseonics Holdings, Inc.

Mkt capRevenueRevenue

RNAAtrium Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SENSSenseonics Holdings, Inc.

RNAAtrium Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SENS1 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.6%▲+36.31%×3.13

RNA2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+4.14%—

Q1 FY26±3.0%▼−0.30%×0.10

= impliedSENS realized, solidRNA realized, hatchedOne scale, both sides: full bar = 37%× = |realized| ÷ impliedSource: market data

SENSSenseonics Holdings, Inc.

8.57▲+7.25%· post 8.57

Mkt cap$454.2MRevenue$14MQ2 FY26Revenue$35MFY25

RNAAtrium Therapeutics, Inc.

8.38▲+0.72%· post 8.38

ClosedNov 6 '26

Mkt cap$142.7MRevenue$3MQ2 FY26Revenue—

Compare

ClosedNov 6 '26

SENSSenseonics Holdings, Inc.

RNAAtrium Therapeutics, Inc.

8.57▲+7.25%post 8.57

Price

8.38▲+0.72%post 8.38

$454.2M

Mkt cap

$142.7M

Q2 FY26$14M

Revenue

$3MQ2 FY26

FY25$35M

Revenue

—

SENS8.57▲+7.25%vsRNA8.38▲+0.72%ClosedNov 6 '26